The cohort included 82% males and 18% females, and children with genetic syndromes, prematurity, major medical disease or severe irritability were excluded, although common comorbidities such as gastrointestinal, allergic, neurological, and sleep disorders were present
- Inhibits the activity of tyrosinase (enzyme), resulting in the suppression of melanin production
Research has shown that etoricoxib rapidly and selectively inhibits COX-2, and its efficacy in terms of treating various clinical manifestations of GA, including pain and inflammation, is comparable to that of indomethacin (210)
Understanding how it fits alongside other commonly paired compounds with tirzepatide helps researchers build coherent protocols rather than haphazard combinations